Curative Biotechnology Inc (CUBT) — Financial Flexibility Index
Curative Biotechnology Inc (CUBT) has a Financial Flexibility Index of -0.03x as of March 2025. Free cash flow of $-185.27K (operating CF $-185.27K minus capex $0.00) represents 0% of total liabilities ($7.28 Million). Also explore CUBT year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Curative Biotechnology Inc Financial Flexibility Index (2013–2025)
Historical Financial Flexibility Index trend for Curative Biotechnology Inc across 13 annual periods. Check strategic asset allocation of Curative Biotechnology Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Curative Biotechnology Inc (2013–2025)
Year-by-year free cash flow to debt coverage for Curative Biotechnology Inc. For the full company profile including market capitalisation, see Curative Biotechnology Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.11x | $-868.86K | $-868.87K | $8.20 Million | ▲ +26.7% |
| 2024 | -0.14x | $-1.02 Million | $-1.02 Million | $7.08 Million | ▼ -75.7% |
| 2023 | -0.08x | $-472.54K | $-486.58K | $5.75 Million | ▼ -27.5% |
| 2022 | -0.06x | $-1.46 Million | $-1.54 Million | $22.62 Million | ▲ +23.5% |
| 2021 | -0.08x | $-1.58 Million | $-1.60 Million | $18.77 Million | ▼ -267.7% |
| 2020 | -0.02x | $-155.79K | $-190.09K | $6.80 Million | ▼ -236.2% |
| 2019 | 0.02x | $6.68K | $-150.00 | $397.10K | ▲ +8340.4% |
| 2018 | 0.00x | $-150.00 | $-150.00 | $734.36K | ▲ +2.2% |
| 2017 | 0.00x | $-150.00 | $-150.00 | $718.33K | ▲ +97.5% |
| 2016 | -0.01x | $-5.89K | $-5.89K | $702.29K | ▼ -394.8% |
| 2015 | 0.00x | $1.96K | $1.96K | $687.16K | ▲ +119.3% |
| 2014 | -0.01x | $-14.16K | $-20.99K | $960.99K | ▼ -291.1% |
| 2013 | 0.01x | $7.19K | $-35.68K | $932.66K | — |